Baxter International (BAX) Depreciation & Amortization (CF) (2009 - 2026)
Baxter International (BAX) posted quarterly Depreciation & Amortization (CF) of $239.0 million for Q2 2026, down 7.0% year-over-year from $257.0 million in Q2 2025, and up 0.84% quarter-over-quarter from $237.0 million in Q1 2026.
Baxter International (BAX) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported Depreciation & Amortization (CF) for 18 consecutive years, with $239.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) fell 7.0% year-over-year to $239.0 million; the TTM figure through Jun 2026 stood at $953.0 million (down 4.99% YoY), while the FY2025 annual figure was $981.0 million, down 1.6% from the prior year.
- Depreciation & Amortization (CF) advanced to $239.0 million in Q2 2026 per BAX's latest filing, from $237.0 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $380.0 million in Q1 2022 and bottomed at $18.0 million in Q4 2022.
- Historically, Depreciation & Amortization (CF) has averaged $250.6 million across 5 years, with a median of $250.5 million in 2024.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) slumped 91.89% — and 2023, when it surged 1366.67%.
- Baxter International's Depreciation & Amortization (CF) stood at $18.0 million in 2022, then soared by 1366.67% to $264.0 million in 2023, then declined by 7.2% to $245.0 million in 2024, then fell by 2.04% to $240.0 million in 2025, then dropped by 0.42% to $239.0 million in 2026.
- Business Quant data shows BAX's Depreciation & Amortization (CF) at $239.0 million in Q2 2026, $237.0 million in Q1 2026, and $240.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 192.30 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 564.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 44.78 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 256.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 133.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 95.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 239.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 40.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 239.00 Mn |
| Jun 30, 2026 | 239.00 Mn |
| Mar 31, 2026 | 237.00 Mn |
| Mar 31, 2026 | 237.00 Mn |
| Dec 31, 2025 | 240.00 Mn |
| Dec 31, 2025 | 240.00 Mn |
| Sep 30, 2025 | 237.00 Mn |
| Sep 30, 2025 | 237.00 Mn |
| Jun 30, 2025 | 257.00 Mn |
| Jun 30, 2025 | 257.00 Mn |
| Mar 31, 2025 | 247.00 Mn |
| Mar 31, 2025 | 247.00 Mn |
| Dec 31, 2024 | 245.00 Mn |
| Dec 31, 2024 | 245.00 Mn |
| Sep 30, 2024 | 254.00 Mn |
| Sep 30, 2024 | 254.00 Mn |
| Jun 30, 2024 | 227.00 Mn |
| Jun 30, 2024 | 227.00 Mn |
| Mar 31, 2024 | 271.00 Mn |
| Mar 31, 2024 | 271.00 Mn |